Table 3.104.
Key considerations for dental management in lupus erythematosus (see text)
Management modifications* | Comments/possible complications | |
---|---|---|
Risk assessment | 2 | Multi-system disease; SLE symptoms exacerbation; infective endocarditis; bleeding tendency |
Appropriate dental care | 2/4 | Bleeding tests; antibiotic prophylaxis; avoid elective dental care during active phases of SLE |
Pain and anxiety control | ||
– Local anaesthesia | 0 | |
– Conscious sedation | 1 | |
– General anaesthesia | 3/4 | Pulmonary disease |
Patient access and positioning | ||
– Access to dental office | 0 | |
– Timing of treatment | 0 | |
– Patient positioning | 0 | |
Treatment modification | ||
– Oral surgery | 2 | Bleeding tests; consider need for antibiotic prophylaxis |
– Implantology | 2 | See oral surgery |
– Conservative/Endodontics | 1 | |
– Fixed prosthetics | 1 | |
– Removable prosthetics | 1 | |
– Non-surgical periodontology | 2 | See oral surgery |
– Surgical periodontology | 2 | See oral surgery |
Hazardous and contraindicated drugs | 2 | Avoid tetracyclines and penicillin; some patients receive corticosteroids or immunosuppressives |
0 = No special considerations. 1 = Caution advised. 2 = Specialised medical advice recommended in some cases. 3 = Specialised medical advice mandatory. 4 = Only to be performed in hospital environment. 5 = Should be avoided.